| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 2.493 | 12.054 | 17.775 | 26.426 | 6.091 | 7.547 | 9.020 |
| Total Income - EUR | - | - | - | 2.529 | 12.271 | 17.775 | 26.426 | 6.091 | 7.547 | 9.020 |
| Total Expenses - EUR | - | - | - | 7.977 | 15.090 | 14.635 | 19.602 | 13.461 | 13.086 | 13.299 |
| Gross Profit/Loss - EUR | - | - | - | -5.448 | -2.819 | 3.141 | 6.825 | -7.370 | -5.539 | -4.279 |
| Net Profit/Loss - EUR | - | - | - | -5.518 | -3.186 | 2.874 | 6.735 | -7.535 | -5.539 | -4.279 |
| Employees | - | - | - | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Saga Oxymed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 28.576 | 26.061 | 21.702 | 27.813 | 22.639 | 17.331 | 12.047 |
| Current Assets | - | - | - | 543 | 1.052 | 423 | 1.272 | 919 | 574 | 1.479 |
| Inventories | - | - | - | 0 | 6 | 6 | 6 | 6 | 6 | 6 |
| Receivables | - | - | - | 346 | 276 | 271 | 265 | 265 | 264 | 263 |
| Cash | - | - | - | 197 | 770 | 146 | 1.001 | 647 | 303 | 1.210 |
| Shareholders Funds | - | - | - | -5.475 | -8.386 | -5.353 | 1.501 | -6.029 | -11.550 | -15.764 |
| Social Capital | - | - | - | 43 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | - | 34.594 | 35.500 | 27.477 | 27.584 | 29.587 | 29.455 | 29.290 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9623 - 9623" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Saga Oxymed S.r.l.